Mithra Pharmaceuticals SA

ENXTBR:MITRA Lagerbericht

Marktkapitalisierung: €12.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mithra Pharmaceuticals Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Christophe Marechal

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer7.6yrs
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements4.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder2.8yrs

Jüngste Management Updates

Recent updates

Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Apr 06
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%

Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Feb 07
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive

Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

Nov 09
Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts

These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Oct 05
These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts

Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

May 23
Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)

Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Aug 11
Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts

Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mar 13
Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%

Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Dec 22
Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 24
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

Jun 07
Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt

When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

May 10
When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?

Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

Mar 18
Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?

We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings

Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Jan 21
Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long

Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 29
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates

Geschäftsführer

Christophe Marechal

7.6yrs

Amtszeit

Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Christophe Marechal
Co-CEO & CFO7.6yrskeine Datenkeine Daten
Xavier Paoli
COO & Co-CEOless than a yearkeine Datenkeine Daten
Graham Dixon
Chief Scientific Officer5.2yrskeine Datenkeine Daten
Alex Sokolowski
Head of Investor Relationsno datakeine Datenkeine Daten
Fanny Rozenberg
Secretary of the Board & General Counselno datakeine Datenkeine Daten
Fanny Storms
Compliance Officerno datakeine Datenkeine Daten
Frederique Depraetere
Communication Directorno datakeine Datenkeine Daten
Catherine Lejeune
HR Directorno datakeine Datenkeine Daten
Jean-Manuel Fontaine
Chief Business Officer3.7yrskeine Daten0.000040%
€ 4.9
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Directorno data€7.12k0.029%
€ 3.6k
Christophe Saillez
Head of Global Regulatory Affairsno datakeine Datenkeine Daten
Maud Jost
Head of Program & Project Managementno datakeine Datenkeine Daten

4.4yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: MITRADas Führungsteam des Unternehmens gilt als erfahren (4.3 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Director8yrs€7.12k0.029%
€ 3.6k
Jacques Platieau
Independent & Non-Executive Director1.7yrs€25.00kkeine Daten
Valerie Gordenne
Non-Executive Director2.8yrs€20.00k0.042%
€ 5.1k

2.8yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: MITRADie Vorstandsmitglieder gelten nicht als erfahren ( 2.7 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.